CNR Institutional Research Information System

BOLZATI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.629
NA - Nord America 1.497
EU - Europa 756
SA - Sud America 665
AF - Africa 62
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.616
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.513
US - Stati Uniti d'America 1.404
CN - Cina 906
BR - Brasile 534
HK - Hong Kong 367
VN - Vietnam 351
FR - Francia 219
KR - Corea 179
IT - Italia 142
NL - Olanda 111
GB - Regno Unito 70
JP - Giappone 70
IN - India 58
AR - Argentina 51
CA - Canada 49
DE - Germania 46
BD - Bangladesh 35
FI - Finlandia 25
ID - Indonesia 25
MX - Messico 23
IL - Israele 22
PL - Polonia 21
CO - Colombia 18
ZA - Sudafrica 17
IQ - Iraq 16
EC - Ecuador 15
RU - Federazione Russa 15
ES - Italia 13
PH - Filippine 12
PK - Pakistan 11
PY - Paraguay 11
VE - Venezuela 11
BE - Belgio 10
EG - Egitto 9
PE - Perù 9
UA - Ucraina 9
IE - Irlanda 8
TR - Turchia 8
UZ - Uzbekistan 8
BG - Bulgaria 7
CL - Cile 7
GR - Grecia 7
MY - Malesia 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
JM - Giamaica 6
LT - Lituania 6
SA - Arabia Saudita 6
AT - Austria 5
AZ - Azerbaigian 5
KG - Kirghizistan 5
RO - Romania 5
SE - Svezia 5
ET - Etiopia 4
MA - Marocco 4
PT - Portogallo 4
SN - Senegal 4
AU - Australia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
TH - Thailandia 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LY - Libia 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
Totale 6.604
Salva come PNG Salva come JPEG
Città #
Singapore 888
Santa Clara 478
Hong Kong 363
Hefei 356
Seoul 178
Lauterbourg 170
San Jose 149
Beijing 144
Ho Chi Minh City 110
Ashburn 92
Hanoi 79
Los Angeles 71
Dallas 61
Tokyo 47
São Paulo 46
Guangzhou 45
New York 28
Buffalo 27
Frankfurt am Main 21
Minamishinagawa 20
Toronto 20
Rio de Janeiro 19
Warsaw 18
Brasília 16
Haiphong 16
Bengaluru 15
Biên Hòa 13
Da Nang 13
Helsinki 12
Hải Dương 12
London 12
Montreal 11
Phoenix 11
Belo Horizonte 10
Brooklyn 8
Brussels 8
Chicago 8
City of London 8
Dublin 8
Elk Grove Village 8
Goiânia 8
Johannesburg 8
Milan 8
Orem 8
Recife 8
Shanghai 8
Athens 7
Campinas 7
Can Tho 7
Chennai 7
Lima 7
Munich 7
Ottawa 7
Padova 7
Tashkent 7
Verona 7
Amsterdam 6
Asunción 6
Atlanta 6
Belém 6
Council Bluffs 6
Curitiba 6
Fortaleza 6
Guarulhos 6
Guayaquil 6
Lappeenranta 6
Manaus 6
Manchester 6
Philadelphia 6
Rome 6
Salvador 6
Baghdad 5
Baku 5
Bình Dương 5
Dhaka 5
Düsseldorf 5
Ha Long 5
Houston 5
Newark 5
Poplar 5
Quận Bình Thạnh 5
Quận Một 5
Turku 5
Vienna 5
Bishkek 4
Cairo 4
Contagem 4
Dakar 4
Glasgow 4
Itajaí 4
João Pessoa 4
Kuala Lumpur 4
Mexico City 4
Montevideo 4
Moscow 4
Nanjing 4
Natal 4
New Delhi 4
Ninh Bình 4
Porto Velho 4
Totale 3.956
Salva come PNG Salva come JPEG
Nome #
Copper(II) and copper(I) complexes with a bidentate hydrazinic dithiocarbazate: synthesis and crystal structures 95
Impact of Different [Tc(N)PNP]-Scaffolds on the Biological Properties of the Small cRGDfK Peptide: Synthesis, In Vitro and In Vivo Evaluations 92
Pharmacological characterization of alpha-MSH-derivatives 87
Assessment of the best N3- donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ) 78
N, n-(dialkylamino)-alkyl substituted Tc-99m-amineamidedithiol (AADT) complexes as diagnostic probes for melanoma. 76
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 73
A Review on the Current State and Future Perspectives of [99mTc]Tc-Housed PSMA-i in Prostate Cancer 72
Preclinical dosimetric studies of Lu-177-scFvD2B and comparison with Lu-177-PSMA-617 and Lu-177-iPSMA endoradiotherapeutic agents 68
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 67
IMPACT OF DIFFERENT [Tc(N)PNP]-FRAMEWORKS ON THE PHARMACOKINETICS OF THE SMALL RGDFK PEPTIDE 66
Evaluation of [99mTc]Tc(CO)3+ moiety labeled ?-melanocyte stimulating hormone derived peptide conjugatesfor potential melanoma imaging 65
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 62
Compendio di radiochimica e radiofarmacia : Radiofarmaci marcati con tecnezio-99m 59
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 58
Improved synthesis on solid phase of dithiocarbamic cRGD-derivative and Tc-99m-radiolabelling 57
[99mTc][Tc(N)PNP43]-Labeled RGD Peptides As New Probes for a Selective Detection of alpha v beta (3) Integrin: Synthesis, Structure-Activity and Pharmacokinetic Studies. 56
Oxo-rhenium(V) mixed-ligand complexes with bidentate functionalized phosphines and tridentate Schiff base ligands 55
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen 54
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 52
SITE-SPECIFIC [99mTc][Tc(CO)3(OH2)3]-LABELED scFvD2B-HysTag FOR SPECT IMAGING OF PSMA IN PROSTATE CANCER 52
Selective Detection of alfa_v beta_3 Integrin Receptors Using [99mTc(N)PNP]-labelled RGDechi Peptides 51
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 51
Development and Characterization of 99mTc-scFvD2B as a Potential Radiopharmaceutical for SPECT Imaging of Prostate Cancer 51
Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 50
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies. 50
Radiopharmacological characterization of 64Cu-labeled alfa-MSH analogs for potential use in imaging of malignant melanoma 50
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 50
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 49
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)(2)NR diphosphinoamine ligands 49
[ 99m Tc][Tc(N)(DASD)(PNP n)] + (DASD = 1,4-Dioxa-8-azaspiro[4,5]decandithiocarbamate, PNP n = Bisphosphinoamine) for Myocardial Imaging: Synthesis, Pharmacological and Pharmacokinetic Studies 49
(Radio)pharmacological characterization of novel alpha-MSH derivatives 49
[99mTc][Tc(N)PNP]-tagging of the small RGDfK peptide: impact of different PNP structures on the labeling and pharmacokinetics of the radioconjugates 49
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 48
Tc-III-based mixed complexes for the design and the development of new SPECT tracers 48
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 48
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 47
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 47
Water-Soluble [Tc(N)(PNP)] Moiety for Room-Temperature 99mTc Labeling of Sensitive Target Vectors 47
Facile preparation of Re-188 radiopharmaceuticals from generator-produced Re-188 perrhenate. 46
Synthesis and characterization of novel hexacoordinated, asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 46
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 46
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example. 45
Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry 45
Synthesis, Characterization, and Initial Biological Evaluation of [99mTc]Tc-Tricarbonyl-labeled DPA-?-MSH Peptide Derivatives for Potential Melanoma Imaging 45
Synthesis, characterization and in vitro cytotoxicity of gallium(iii)-dithiocarbamate complexes 45
Folic Acid-Conjugated Europium Complexes as Luminescent Probes for Selective Targeting of Cancer Cells 45
Synthesis and characterization of novel asymmetrical M(III) (M = Re, Tc-99g) complexes as models for the development of new potential tracers for SPECT imaging and radiotherapy 44
Radioactive Transition Metal Nitride Hetero-Complex 44
[Tc-99m(N)PNP]-scaffold for SPECT of multidrug resistance: Early in-vitro study 44
Reactivity of the [M(PS)2](+) Building Block (M = Re(III) and (99m)Tc(III); PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate. 44
Zirconium immune-complexes for PET molecular imaging: Current status and prospects 43
Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 43
Cu-64-labelled compounds with dithiocarbamate ligands for theragnostic applications: preliminary in vitro studies 43
Melanoma targeting with [(TcN)-Tc-99m(PNP3)]-labeled alpha-MSH peptide analogs: Preliminary studies 43
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 42
Chelating Systems for Tc-99m/Re-188 in the Development of Radiolabeled Peptide Pharmaceuticals 41
'3+1' mixed-ligand oxotechnetium(V) complexes with affinity for melanoma: Synthesis and evaluation in vitro and in vivo 40
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 40
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy. 40
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 40
Synthesis and characterization of rhenium(III) complexes with pincer-like PNP(R) ligands 39
Water-soluble [Tc(N)(PNP)]-moiety for the room temperature labeling of sensitive molecules 39
The emerging value of Cu-64 for molecular imaging and therapy 38
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 38
, [188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 38
Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy 38
[188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 38
Nitrido technetium-99m core in radiopharmaceutical applications: Four decades of research 38
LC-MS and MALDI-TOF supported metabolism studies of the selective ?v?3 RGDechi peptide and of thecorresponding [99mTc(N)PNP]-tagged derivatives. 38
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 37
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 37
Synthesis and characterization of Oxorhenium(V) Complexes Containing o-diphenylphosphinophenolato and monothiolato lingands 36
Mixed Technetium-99m Nitrido Complexes with Dithiocarbamate and Phosphine-Thiol Ligands 36
Synthesis and biological evaluation of [188Re(N)(CYS~)(PNP)]+/0 complexes as prototypes for the development of [188Re(N)(PNP)-based target vectors 36
Cu-64-dithiocarbamate compounds for theragnostic applications: Preliminary in-vitro studies 36
The emerging value of copper-64 for molecular imaging and therapy. 36
A Bis(Thiosemicarbazone) bifunctional chelating agent for Nitrido-Tchnetium-99m and Copper 64-basedRadiopharmaceuticals 36
Synthesis, characterization and biological evaluation of [(188)Re(N)(cys similar to)(PNP)](+/0) mixed-ligand complexes as prototypes for the development of (188)Re(N)-based target-specific radiopharmaceuticals 36
Low-Valent Technetium Complexes with Aminodiphosphines 35
99mTc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study 35
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 34
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 33
Biologically relevant Cu2+ complexes with a tridentate phenanthroline analogue: Structural properties and DNA damage 33
New Tc-99m-radioimmunoconjugates for pancreatic carcinoma detection 33
A New series of [99mTc(N)(DTC)(PNP)]+ complexes as potential myocardial imaging agents 33
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 33
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imagin and radiotherapy 33
The (Tc(N)(PNP))(2+) metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies 33
99mTc-Radiolabeled Peptides for Tumour Imaging: Present and Future 33
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 32
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 32
Radiochemical and radiopharmacological characterization of a Cu-64-labeled alpha-MSH analog conjugated with different chelators 31
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 31
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 30
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 30
Alternative Synthesis of Aminodiphosphines 30
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 29
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 29
The metal-fragment strategy for the construction of stable Tc and Re mixed-ligand compounds relevant to nuclear medicine 29
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 29
Totale 4.551
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.613
article - articoli 14.708
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 430
Totale 38.751
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202470 0 0 0 0 0 0 0 0 2 0 66 2
2024/20252.579 20 10 198 109 418 118 60 158 75 116 707 590
2025/20264.001 242 390 445 664 692 144 613 217 188 283 123 0
Totale 6.650